TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TARA

Protara Therapeutics Inc

Healthcare · Biotechnology

3.30$ -2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow TARA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-338.9% – – – – – – – – – – –
1.0% – – – – – – – – – – –
15.6% – – – – – – – – – – –
18.3% – – – – – – – – – – –
3.7% – – – – – – – – – – –
1.7% – – – – – – – – – – –
-423.4% – – – – – – – – – – –
3,018.0% – – – – – – – – – – –
3,002.7% – – – – – – – – – – –
2,240.4% – – – – – – – – – – –
-340.6% – – – – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?